A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition in Enhancing Long-Acting Drug Delivery.

Authors:
Vora LK; Tekko IA; Zanutto FV; Sabri A; Choy RKM and 5 more

Journal:
Pharmaceutics

Publication Year: 2024

DOI:
10.3390/pharmaceutics16010142

PMCID:
PMC10819247

PMID:
38276512

Journal Information

Full Title: Pharmaceutics

Abbreviation: Pharmaceutics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest Ryan F. Donnelly is the inventor of patents that have been licensed to companies developing microneedle-based products and a paid advisor to companies developing microneedle-based products. The potential conflict of interest has been disclosed and is being managed by Queen’s University Belfast. The remaining authors declare no conflict of interest."

Evidence found in paper:

"This work was made possible by the generous support of the American people through the United States Agency for International Development (USAID) through the United States President’s Emergency Plan for AIDS Relief (PEPFAR) under the terms of Cooperative Agreement #AID-OAA-A-17-00015. The contents are the responsibility of Queen’s University Belfast and PATH and do not necessarily reflect the views of USAID, PEPFAR, or the United States government. This project is also supported in part by EPSRC (grant number EP/S028919/1)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025